Zacks: Analysts Anticipate Merit Medical Systems, Inc. (MMSI) to Announce $0.45 Earnings Per Share
Analysts expect that Merit Medical Systems, Inc. (NASDAQ:MMSI) will report earnings per share of $0.45 for the current quarter, according to Zacks. Five analysts have made estimates for Merit Medical Systems’ earnings, with the highest EPS estimate coming in at $0.48 and the lowest estimate coming in at $0.43. Merit Medical Systems posted earnings per share of $0.33 in the same quarter last year, which would indicate a positive year-over-year growth rate of 36.4%. The business is scheduled to announce its next earnings results on Wednesday, February 27th.
On average, analysts expect that Merit Medical Systems will report full-year earnings of $1.66 per share for the current year, with EPS estimates ranging from $1.64 to $1.67. For the next financial year, analysts expect that the firm will post earnings of $1.93 per share, with EPS estimates ranging from $1.90 to $1.98. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that follow Merit Medical Systems.
Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, October 25th. The medical instruments supplier reported $0.47 EPS for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.05. The business had revenue of $221.66 million for the quarter, compared to analyst estimates of $217.62 million. Merit Medical Systems had a net margin of 4.72% and a return on equity of 10.86%.
In other Merit Medical Systems news, COO Ronald Frost sold 5,257 shares of the company’s stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $61.31, for a total transaction of $322,306.67. Following the sale, the chief operating officer now directly owns 5,257 shares of the company’s stock, valued at $322,306.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director F. Ann Millner sold 9,593 shares of the company’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $56.92, for a total transaction of $546,033.56. Following the sale, the director now directly owns 7,891 shares in the company, valued at $449,155.72. The disclosure for this sale can be found here. Corporate insiders own 5.00% of the company’s stock.
Several large investors have recently added to or reduced their stakes in MMSI. BlackRock Inc. increased its holdings in shares of Merit Medical Systems by 13.3% in the third quarter. BlackRock Inc. now owns 7,985,361 shares of the medical instruments supplier’s stock valued at $490,700,000 after purchasing an additional 939,589 shares during the last quarter. Partner Fund Management L.P. increased its holdings in shares of Merit Medical Systems by 69.9% in the second quarter. Partner Fund Management L.P. now owns 1,455,616 shares of the medical instruments supplier’s stock valued at $74,528,000 after purchasing an additional 598,822 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Merit Medical Systems by 10,444.4% in the second quarter. Advisors Asset Management Inc. now owns 471,864 shares of the medical instruments supplier’s stock valued at $219,000 after purchasing an additional 467,389 shares during the last quarter. Peregrine Capital Management LLC acquired a new position in shares of Merit Medical Systems in the third quarter valued at $25,196,000. Finally, Frontier Capital Management Co. LLC increased its holdings in shares of Merit Medical Systems by 74.8% in the second quarter. Frontier Capital Management Co. LLC now owns 916,409 shares of the medical instruments supplier’s stock valued at $46,920,000 after purchasing an additional 392,203 shares during the last quarter. Hedge funds and other institutional investors own 87.09% of the company’s stock.
Shares of MMSI stock opened at $59.16 on Monday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.47 and a current ratio of 2.77. The firm has a market capitalization of $3.34 billion, a PE ratio of 46.22, a price-to-earnings-growth ratio of 2.82 and a beta of 1.19. Merit Medical Systems has a 12 month low of $36.21 and a 12 month high of $66.34.
About Merit Medical Systems
Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.
Featured Article: What factors cause inflation to rise?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.